Ya‐Min Tsai

509 total citations
16 papers, 236 citations indexed

About

Ya‐Min Tsai is a scholar working on Infectious Diseases, Immunology and Animal Science and Zoology. According to data from OpenAlex, Ya‐Min Tsai has authored 16 papers receiving a total of 236 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 5 papers in Immunology and 4 papers in Animal Science and Zoology. Recurrent topics in Ya‐Min Tsai's work include SARS-CoV-2 and COVID-19 Research (9 papers), COVID-19 Clinical Research Studies (5 papers) and Animal Virus Infections Studies (4 papers). Ya‐Min Tsai is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (9 papers), COVID-19 Clinical Research Studies (5 papers) and Animal Virus Infections Studies (4 papers). Ya‐Min Tsai collaborates with scholars based in Taiwan and Russia. Ya‐Min Tsai's co-authors include Mao‐Liang Chen, Tzung‐Chieh Tsai, Fu‐Ming Tsai, Lu‐Kai Wang, Sui‐Yuan Chang, Tai‐Ling Chao, Ming‐Chang Hsieh, Lily Wang, Po‐Huang Liang and Chih‐Jung Kuo and has published in prestigious journals such as The Journal of Experimental Medicine, SHILAP Revista de lepidopterología and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Ya‐Min Tsai

15 papers receiving 232 citations

Peers

Countries citing papers authored by Ya‐Min Tsai

Since Specialization

Citations

This map shows the geographic impact of Ya‐Min Tsai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ya‐Min Tsai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ya‐Min Tsai more than expected).

Fields of papers citing papers by Ya‐Min Tsai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ya‐Min Tsai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ya‐Min Tsai. The network helps show where Ya‐Min Tsai may publish in the future.

Co-authorship network of co-authors of Ya‐Min Tsai

This figure shows the co-authorship network connecting the top 25 collaborators of Ya‐Min Tsai. A scholar is included among the top collaborators of Ya‐Min Tsai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ya‐Min Tsai. Ya‐Min Tsai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Emergence of conjugative metallo-β-lactamase-encoding plasmids in the Klebsiella pneumoniae species complex: First identification of IMP-8-MCR-9.1 in K. quasipneumoniae and VIM-1 in K. variicola in Taiwan 2025 ·Journal of Infection and Public Health ·(unknown), (unknown), (unknown), Dingsheng Lin, (unknown), (unknown), Ya‐Min Tsai, Yu‐Tsung Huang, Yu‐Chen Chen, (unknown), Wei‐Hung Lin, Cheng‐Yen Kao	0
2	IFN‐stimulated metabolite transporter ENT3 facilitates viral genome release 2023 ·EMBO Reports ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Tai‐Ling Chao, Ya‐Min Tsai, Pei‐Ching Chang, Chien‐Kuo Lee, Guann‐Yi Yu, Sui‐Yuan Chang, Ivan Dzhagalov, Chia‐Lin Hsu	2
3	Elicitation of potent neutralizing antibodies in obese mice by ISA 51-adjuvanted SARS-CoV-2 spike RBD-Fc vaccine 2023 ·Applied Microbiology and Biotechnology ·Chia‐Jung Li, (unknown), Tai‐Ling Chao, (unknown), Ya‐Min Tsai, (unknown), Yuting Su, Chun‐Jen Chen, Sui‐Yuan Chang, Fu‐Jung Lin, Shih‐Chung Chang	3
4	The Src–ZNRF1 axis controls TLR3 trafficking and interferon responses to limit lung barrier damage 2023 ·The Journal of Experimental Medicine ·You-Sheng Lin, Yung‐Chi Chang, Tai‐Ling Chao, Ya‐Min Tsai, (unknown), (unknown), Ting‐Yu Lai, Yiling Liu, Chiung-Ya Chen, Ching‐Yen Tsai, Yi‐Ping Hsueh, Sui‐Yuan Chang, Tsung‐Hsien Chuang, Chih‐Yuan Lee, Li‐Chung Hsu	4
5	Evolution of neutralizing antibodies and cross-activity against different variants of SARS-CoV-2 in patients recovering from COVID-19 2022 ·Journal of the Formosan Medical Association ·Wang-Da Liu, Jann‐Tay Wang, Tai‐Ling Chao, (unknown), Ya‐Min Tsai, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Yu‐Shan Huang, Chien‐Ching Hung, Yee‐Chun Chen, Sui‐Yuan Chang, Shan‐Chwen Chang, (unknown), (unknown)	3
6	Clinical assessment of SARS-CoV-2 infectivity by rapid antigen test compared with virus isolation 2022 ·SHILAP Revista de lepidopterología ·Tai‐Ling Chao, (unknown), (unknown), Yi‐Chun Lin, (unknown), (unknown), Cheng‐Pin Chen, Ya‐Min Tsai, (unknown), (unknown), Yu‐Chen Cheng, (unknown), Shu‐Hsing Cheng, Chien‐Yu Cheng, Sui‐Yuan Chang	3
7	Neutralization or enhancement of SARS-CoV-2 infection by a monoclonal antibody targeting a specific epitope in the spike receptor-binding domain 2022 ·Antiviral Research ·(unknown), Tai‐Ling Chao, (unknown), (unknown), Ya‐Min Tsai, (unknown), (unknown), Sui‐Yuan Chang, Shih‐Chung Chang	6
8	A Longitudinal Nine-Year Study of the Molecular Epidemiology of Carbapenemase-Producing Enterobacterales Isolated From a Regional Hospital in Taiwan: Predominance of Carbapenemase KPC-2 and OXA-48 2022 ·Frontiers in Microbiology ·Thi Thuy Duong, Ya‐Min Tsai, Li‐Li Wen, (unknown), (unknown), (unknown), Pei-Yun Kuo, (unknown), Shining Wang, (unknown), Wei‐Hung Lin, Mingcheng Wang, Cheng‐Yen Kao	5
9	Disulfiram blocked cell entry of SARS-CoV-2 via inhibiting the interaction of spike protein and ACE2. 2022 ·PubMed ·Hsiao‐Fan Chen, Po‐Ren Hsueh, Yen‐Yi Liu, Yeh Chen, Sui‐Yuan Chang, Wei‐Jan Wang, (unknown), Ya‐Min Tsai, (unknown), Wen‐Chi Su, Yu‐Chi Chou, Mien‐Chie Hung	16
10	Neutralizing Monoclonal Antibodies Inhibit SARS-CoV-2 Infection through Blocking Membrane Fusion 2022 ·Microbiology Spectrum ·Chia‐Jung Li, Tai‐Ling Chao, (unknown), (unknown), (unknown), (unknown), (unknown), Ya‐Min Tsai, (unknown), (unknown), Jann‐Tay Wang, Sui‐Yuan Chang, Shih‐Chung Chang	19
11	Tag-Free SARS-CoV-2 Receptor Binding Domain (RBD), but Not C-Terminal Tagged SARS-CoV-2 RBD, Induces a Rapid and Potent Neutralizing Antibody Response 2022 ·Vaccines ·Ting‐Wei Lin, (unknown), (unknown), Tai‐Ling Chao, Ya‐Min Tsai, Shih‐Chung Chang, Sui‐Yuan Chang, Hui‐Wen Chen	4
12	Kinetic Characterization and Inhibitor Screening for the Proteases Leading to Identification of Drugs against SARS-CoV-2 2021 ·Antimicrobial Agents and Chemotherapy ·Chih‐Jung Kuo, Tai‐Ling Chao, (unknown), Ya‐Min Tsai, (unknown), Lily Wang, Ming‐Chang Hsieh, Sui‐Yuan Chang, Po‐Huang Liang	34
13	Furin Inhibitors Block SARS-CoV-2 Spike Protein Cleavage to Suppress Virus Production and Cytopathic Effects 2020 ·SSRN Electronic Journal ·Ya‐Wen Cheng, Tai‐Ling Chao, (unknown), (unknown), (unknown), Shenghan Wang, (unknown), (unknown), Ya‐Min Tsai, (unknown), Mi‐Hua Tao, (unknown), Ping‐Yi Wu, (unknown), Pei‐Jer Chen, Sui‐Yuan Chang, Shiou‐Hwei Yeh	3
14	Clozapine inhibits Th1 cell differentiation and causes the suppression of IFN-γ production in peripheral blood mononuclear cells 2012 ·Immunopharmacology and Immunotoxicology ·Mao‐Liang Chen, Tzung‐Chieh Tsai, Lu‐Kai Wang, (unknown), Ya‐Min Tsai, (unknown), Fu‐Ming Tsai	35
15	Risperidone modulates the cytokine and chemokine release of dendritic cells and induces TNF-α-directed cell apoptosis in neutrophils 2011 ·International Immunopharmacology ·Mao‐Liang Chen, Tzung‐Chieh Tsai, Lu‐Kai Wang, (unknown), Ya‐Min Tsai, (unknown), Fu‐Ming Tsai	51
16	Antipsychotic drugs suppress the AKT/NF-κB pathway and regulate the differentiation of T-cell subsets 2011 ·Immunology Letters ·Mao‐Liang Chen, Tzung‐Chieh Tsai, (unknown), Ya‐Min Tsai, Lu‐Kai Wang, (unknown), Fu‐Ming Tsai	48

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact